• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNase 介导的 eDNA 去除增强 D-LL-31 对慢性鼻鼻窦炎患者分离的细菌生物膜的活性。

DNase-mediated eDNA removal enhances D-LL-31 activity against biofilms of bacteria isolated from chronic rhinosinusitis patients.

机构信息

Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

出版信息

Biofouling. 2020 Oct;36(9):1117-1128. doi: 10.1080/08927014.2020.1857741. Epub 2020 Dec 9.

DOI:10.1080/08927014.2020.1857741
PMID:33297738
Abstract

Chronic rhinosinusitis (CRS) is a chronic infection of the nasal cavity and paranasal sinuses associated with the presence of a microbial biofilm. Extracellular DNA (eDNA) is an important component of the biofilm matrix. Antimicrobial peptides (AMPs) are natural peptides with the ability to kill microorganisms. D-LL-31 is a synthetic variant of the AMP cathelicidin with increased resistance to proteolytic breakdown. In this study it is shown for 3 clinical CRS isolates that treatment of 24 h biofilms with DNase I enhanced the antimicrobial activity of D-LL-31. Conversely, co-incubation of D-LL-31 at the IC value with exogenous DNA resulted in reduced antimicrobial activity. DNase I alone did not show antimicrobial activity against the isolates tested but caused dispersal of an established biofilm. Hence, the presence of eDNA in the biofilm matrix reduced AMP-mediated killing. These results suggest that combination therapy with proteolysis resistant AMP D-LL-31 and DNase could be considered for effective treatment of CRS.

摘要

慢性鼻-鼻窦炎(CRS)是一种鼻腔和鼻窦的慢性感染,与微生物生物膜的存在有关。细胞外 DNA(eDNA)是生物膜基质的重要组成部分。抗菌肽(AMPs)是具有杀死微生物能力的天然肽。D-LL-31 是抗菌肽 cathelicidin 的一种合成变体,具有增强的抗蛋白水解破坏的能力。在这项研究中,对 3 株临床 CRS 分离株进行了研究,结果表明,用 DNA 酶 I 处理 24 小时生物膜可增强 D-LL-31 的抗菌活性。相反,将 D-LL-31 在 IC 值与外源性 DNA 共孵育会导致抗菌活性降低。DNA 酶 I 单独对测试的分离株没有抗菌活性,但会导致已建立的生物膜的分散。因此,生物膜基质中 eDNA 的存在降低了 AMP 介导的杀伤作用。这些结果表明,使用蛋白酶抗性 AMP D-LL-31 和 DNA 酶的联合治疗可能被认为是治疗 CRS 的有效方法。

相似文献

1
DNase-mediated eDNA removal enhances D-LL-31 activity against biofilms of bacteria isolated from chronic rhinosinusitis patients.DNase 介导的 eDNA 去除增强 D-LL-31 对慢性鼻鼻窦炎患者分离的细菌生物膜的活性。
Biofouling. 2020 Oct;36(9):1117-1128. doi: 10.1080/08927014.2020.1857741. Epub 2020 Dec 9.
2
D-LL-31 enhances biofilm-eradicating effect of currently used antibiotics for chronic rhinosinusitis and its immunomodulatory activity on human lung epithelial cells.D-LL-31 增强了慢性鼻-鼻窦炎常用抗生素的生物膜清除作用及其对人肺上皮细胞的免疫调节活性。
PLoS One. 2020 Dec 16;15(12):e0243315. doi: 10.1371/journal.pone.0243315. eCollection 2020.
3
D-LL-31 in combination with ceftazidime synergistically enhances bactericidal activity and biofilm destruction in .D-LL-31 与头孢他啶联合使用可协同增强杀菌活性和破坏生物膜。
Biofouling. 2019 May;35(5):573-584. doi: 10.1080/08927014.2019.1632835. Epub 2019 Jul 8.
4
Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics.鸟分枝杆菌拥有有助于生物膜形成、结构完整性和抗生素耐受性的细胞外DNA。
PLoS One. 2015 May 26;10(5):e0128772. doi: 10.1371/journal.pone.0128772. eCollection 2015.
5
Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37.铜绿假单胞菌生物膜对α-螺旋肽的敏感性:LL-37 的 D-对映体。
Front Microbiol. 2011 Jul 4;2:128. doi: 10.3389/fmicb.2011.00128. eCollection 2011.
6
Efficacy of a marine bacterial nuclease against biofilm forming microorganisms isolated from chronic rhinosinusitis.海洋细菌核酸酶对慢性鼻-鼻窦炎分离的生物膜形成微生物的疗效。
PLoS One. 2013;8(2):e55339. doi: 10.1371/journal.pone.0055339. Epub 2013 Feb 18.
7
[The Role of eDNA in Biofilm Structure of Enterococcus faecalis and Investigation of the Efficiency of Enzyme and Antibiotic Application in Biofilm Eradication].[胞外DNA在粪肠球菌生物膜结构中的作用以及酶和抗生素在生物膜根除中的应用效率研究]
Mikrobiyol Bul. 2022 Oct;56(4):606-619. doi: 10.5578/mb.20229602.
8
DNase increases the efficacy of antimicrobial photodynamic therapy on Candida albicans biofilms.DNase 提高了抗微生物光动力疗法对白色念珠菌生物膜的疗效。
Photodiagnosis Photodyn Ther. 2019 Sep;27:124-131. doi: 10.1016/j.pdpdt.2019.05.038. Epub 2019 May 29.
9
Biofilm-Forming Ability and Effect of Sanitation Agents on Biofilm-Control of Thermophile sp. D413 and E134.耐热菌 D413 和 E134 的生物膜形成能力及卫生处理剂对生物膜控制的效果。
Pol J Microbiol. 2020 Dec;69(4):411-419. doi: 10.33073/pjm-2020-042. Epub 2020 Nov 23.
10
Co-immobilization of cellobiose dehydrogenase and deoxyribonuclease I on chitosan nanoparticles against fungal/bacterial polymicrobial biofilms targeting both biofilm matrix and microorganisms.壳聚糖纳米粒子上细胞二糖脱氢酶和脱氧核糖核酸酶 I 的共固定化,针对真菌/细菌多微生物生物膜,靶向生物膜基质和微生物。
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110499. doi: 10.1016/j.msec.2019.110499. Epub 2019 Nov 28.

引用本文的文献

1
Extracellular defense of bacteria against antimicrobial peptides.细菌对抗菌肽的细胞外防御
J Bacteriol. 2025 Aug 21;207(8):e0016625. doi: 10.1128/jb.00166-25. Epub 2025 Aug 1.
2
inhibition of PAO1 biofilm formation by DZ2002 through regulation of extracellular DNA and alginate production.通过调控胞外 DNA 和海藻酸盐产生抑制 PAO1 生物膜形成的 DZ2002。
Front Cell Infect Microbiol. 2024 Jan 10;13:1333773. doi: 10.3389/fcimb.2023.1333773. eCollection 2023.
3
Cell Wall Phenotypic Changes Associated with Biofilm Maturation and Water Availability: A Key Contributing Factor for Chlorine Resistance.
细胞壁表型变化与生物膜成熟和水分可用性有关:氯抗性的一个关键影响因素。
Int J Mol Sci. 2023 Mar 5;24(5):4983. doi: 10.3390/ijms24054983.
4
Biofilm Signaling, Composition and Regulation in .生物膜信号转导、组成和调控在. 中的作用。
J Microbiol Biotechnol. 2023 Jan 28;33(1):15-27. doi: 10.4014/jmb.2207.07032. Epub 2022 Oct 17.
5
DNase inhibits early biofilm formation in - or -induced empyema models.DNase 抑制 - 或 - 诱导的脓胸模型中的早期生物膜形成。
Front Cell Infect Microbiol. 2022 Oct 12;12:917038. doi: 10.3389/fcimb.2022.917038. eCollection 2022.